Company Overview of Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc., a biotechnology company, engages in the development and commercialization of drugs/therapeutics for the treatment of dermatological disorders. Its products include EXC 001, an antisense medicine for reducing fibrosis, the amelioration of skin scarring, and other fibrotic disorders/diseases. Excaliard Pharmaceuticals was founded in 2006 and is based in Carlsbad, California. As of November 30, 2011, Excaliard Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.
2141 Palomar Airport Road
Carlsbad, CA 92011
Founded in 2006
Key Executives for Excaliard Pharmaceuticals, Inc.
Similar Private Companies By Industry
|DEKALB Genetics Corporation||United States|
|Metheor Therapeutics Corporation||United States|
|Vidus Ocular, Inc.||United States|
|Carolus Therapeutics, Inc.||United States|
|Liquidia Technologies, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Excaliard Pharmaceuticals, Inc., please visit excaliard.com. Company data is provided by Capital IQ. Please use this form to report any data issues.